T he presence of a hepatic neoplasm is one of the indications for hepatic transplantation. Currently less than 10% of hepatic transplant t tation is performed for hepatic malignancy.
BACKGROUND:
Hepatic neoplasms can be the primary indication for hepatic transplantation. The tumors can also be incidentally identified in explanted livers. We explored the clinicopathologic features of hepatic neo--plasms identified in explanted livers.
MATERIALS AND METHODS:
All explanted livers resected between 2001 and 2006 were evaluated for the presence of neoplasms and their clinicopathologic features were examined. RESULTS: In 98 liver transplants, 15 neoplasms (15.3%) were identified. Patient ages ranged from 5 to 63 years (median, 56 years). The primary etiology of hepatic disease was hepatitis C virus in 12 cases, hepatitis B virus in 1 case, cryptogenic cirrhosis in 1 case and congenital hepatic fibrosis in 1 case. Serum alpha-fetoprotein was significantly elevated (>400 U/L) in only 2 cases. CA19-9 was not elevated in any of the cases. The tumors included hepatocellular carcinoma (HCC) in 13 cases, 1 case of cholangiocarcinoma and 1 case of combined HCC and hepatoblastoma. The tumors ranged in size from 0.5 to 5 cm (median 1.4 cm) and were multifocal in 5 of the cases (33%). Tissue alpha-fetoprotein expression was only seen in the cases associated with elevated serum levels. CONCLUSION: In our institution hepatic neoplasms are seen in more than 15% of explanted livers. They can be incidentally identified, are frequently not associated with elevated serum levels of alpha-fetoprotein and CA19-9, are commonly multifocal but small, and are associated with good prognosis. Elevated serum alphafetoprotein, albeit specific, is not a very sensitive marker in the detection of hepatic neoplasms. study we attempted to analyze clinicopathologic paramt t eters of hepatic neoplasms identified in explanted livt t ers in our institution to see if we could identify features that would help us more properly manage patients with endtstage liver disease preparing for transplantation.
MATERIALS AND METHODS
All explanted livers resected for hepatic transplantation at King Faisal Specialist Hospital and Research Center between the years 2001 and 2006 were reviewed. Cases with the diagnosis of a hepatic neoplasm were selected. The slides and reports pertaining to the resected liver were reviewed. The tumors were histologically evalut t ated by three pathologists (WAM, MAO and HA). The tumor size was obtained from the gross patholt t ogy report and the tumors were classified and graded according to the Edmondson grading system for hepat t tocellular carcinoma. 10 Immunohistochemical stains for alphatfetoprotein and CA19t9 were performed in all cases. CD34 immunostaining was performed for lowt grade neoplasm to highlight the vascular pattern of the neoplasms. Patient charts were reviewed. The clinical data pertaining to age, sex and primary hepatic disease were tabulated. Laboratory findings related to serum levels of alphatfetoprotein and serum CA19t9 pret and postttransplantation were also obtained from patient charts. Clinical status related to patient condition in ret t lation to survival, recurrence of tumor and serum levels of alphatfetoprotein and CA19t9 at last follow up were also recorded.
RESULTS
There were 98 hepatic transplantations performed in our institution between the years 2001 and 2006 and 15 neoplasms, representing 15.3% of all transplants, were identified. Patient ages ranged from 5 to 63 years (median, 56 years). There was only one child among the group of transplanted patients that had a hepatic neoplasm. The primary underlying indication for transt t plantation was hepatitis C in 12 cases (80%), hepatitis B in one case, cryptogenic hepatitis in one case and cont t genital hepatic fibrosis in one case.
Serum alphatfetoprotein was significantly elevated (>400 U/L) in only two patients (6.6%). One patient had serum alphatfetoprotein of 10 000 U/L and the other had a level of 700 U/L. None of the patients had an elevated level of serum CA19t9.
Clinical and radiologic suspicion of the presence of neoplasm was present in 13 of the patients. Two patients had no preoperative clinical suspicion for the presence of neoplasm.
Of the 15 tumors identified, hepatocellular carcit t noma was seen in 13 cases (86.6%). There was one case of cholangiocarcinoma and one case of combined het t patocellular carcinoma and hepatoblastoma. The tumor grade was Edmonson grade 1 in two cases, grade 2 in 11 cases and grade 3 in one case. The two lowtgrade tumors required the use of CD34 immunostain to highlight the vascular pattern of the neoplastic nodule in comparison to the diseased liver (Figure 1a, b) . Only two cases showed expression of alphatfetoprotein in the neoplasm including a case of hepatoblastoma and hightgrade hepatocellular carcinoma (Figure 2a, b) . This corresponded to the two cases showing elevated serum levels.
The 15 tumors ranged in size from 0.5 cm to 5.0 cm in greatest diameter with a median diameter of 1.4 cm. The tumors were multifocal and microscopic in five of the cases (33%). Four tumors (26.6%) were missed on initial pathologic examination and identified upon pathological retexamination of the explanted liver at the request of the transplantation surgeon.
The only pediatric patient in our series was an 8t yeartold female with a history of congenital hepatic fibrosis. She presented with markedly elevated serum alphatfetoprotein (10 000 U/L). No evidence of a neot t plasm was clinically or radiologically suspected. After the liver was explanted a critical review of the CT scan of the liver showed focal hypodense hepatic lesions in segment #7 (Figure 3 ). She received a livingtrelated liver transplantation. Examination of the liver showed endt stage hepatic cirrhosis with multiple microscopic foci of hepatocellular carcinoma and hepatoblastoma ( Figure  4a, b) . Several weeks posttoperatively the serum levels of alphafetoprotein returned to normal. The patient was free of disease one year after transplantation.
Followtup information ranging from 4 to 48 months was available on all patients with a median follow up pet t riod of 20 months. Two patients died of primary graft failure and all other patients are alive with no evidence of recurrence or residual disease.
DISCUSSION
Hepatocellular carcinoma shows tissue expression of alphatfetoprotein in 20% to 40% of cases. 10 Tissue expression in our series was seen in only 13.3% of the cases. It has been shown that tissue expression of alphat fetoprotein corresponds to high serum levels and hight grade tumors. 11 This finding was confirmed in our series where tissue expression corresponded to serum levels of alphatfetoprotein. The only two cases that showed tist t sue expression of alphafetoprotein had elevated serum levels. The cases were hightgrade hepatocellular carcit t noma and hepatoblastoma. This finding suggests that most hepatocellular carcinomas do not express alphat fetoprotein either at the tissue level or at the secretory level. This indicates the low sensitivity of the test and suggests the need for a more sensitive test for early det t tection of hepatocellular carcinoma.
The rate of incidentally identified neoplasm in ext t planted livers ranges from 10% to 50% of the cases depending on the study. 3, 12 This rate depends on how closely patients with endtstage hepatic disease are folt t lowed. The rate is low in developing countries and hight t er in developed ones. We found incidental neoplasms in 13% of our series. Four cases required repeated gross inspection of the explanted liver to identify the neot t plasm upon request of the transplant surgeon. This was mainly due to the small size of the tumors. The tumors were also well differentiated in many incidents requirt t ing the use of immunohistochemistry to differentiate the nodules from the cirrhotic reparative nodules. It therefore appears that it is extremely important to thort t oughly examine explanted livers to identify small mult t tifocal neoplasms.
Tumor size and grade are two of the most significant prognostic indicators in hepatocellular carcinoma. In one study, large tumor size and high tumor grade could predict vascular invasion and a poor outcome. 13 Another study showed that tumor size together with Kit67 prot t liferation index and p53 expression are the most signifit t cant prognostic indicators. None of our patients suct t cumbed to their diseases. This may be mainly explained by the predominantly small size of the primary tumors Patients with chronic endtstage hepatic disease who develop clinical or radiographic evidence of a neoplasm are candidates for hepatic transplantation, especially if the tumor is resectable with no evidence of metastasis. This is especially true when the tumor is associated with marked elevation of serum alphatfetoprotein.
Serum levels of alphatfetoprotein have been shown to be markedly elevated in more than 60% of cases of hepatocellular carcinoma. 6, 10 Levels above 400 U/L have been suggested as a surrogate test for the presence of a neoplasm. 16 Although high levels have been seen in nontneoplastic conditions of the liver such as hepatit t tis C, this occurrence is not very frequent. 15 These levt t els would, however, rarely reach levels associated with neoplasms (>400 U/L). In our series, we did not see a high incidence of elevated serum alphafetoprotein. Less than 20% of our cases were associated with markedly elevated levels of serum alphatfetoprotein. Extremely high levels of serum alphat fetoprotein have been linked with poor prognostic indicators such as large tumors, vascular invasion and poor survival. 16 Our patients had smaller tumors and better survival.
Paradoxically, one of our patients had extremely high levels of alphatfetoprotein without any clinical or radiographic evidence of a neoplasm. The resected liver showed multiple microscopic foci of hepatocellular carcinoma and hepatoblastoma. This may indicate that extremely high levels of alphatfetoprotein may be seen in the absence of clinically or radiologically detectable tumor. This also suggests the level of serum expression of alpha fetotprotein may be related to individual cell expression of the protein usually seen in high grade neoplasms and hepatoblastoma rather than being ret t lated to tumor size or vascular invasion. It thus seems that markedly elevated levels of serumtalphatfetoprot t tein in patients with longtstanding chronic liver disease with failure may be suggestive of a hepatic neoplasm and an indication for hepatic transplantation even in the absence of a clinically or radiologically detectable tumor. 
